CUL4B-DDB1-COP1-mediated UTX downregulation promotes colorectal cancer progression
Background UTX (encoded by KDM6A), a histone demethylase for H3K27me2/3, is frequently mutated in human cancers. However, its functional and regulatory mechanisms in colorectal cancer (CRC) remain unclear. Methods Immunohistochemistry staining was used to investigate the clinical relevance of UTX in...
Saved in:
| Published in | Experimental hematology & oncology Vol. 12; no. 1; pp. 1 - 21 |
|---|---|
| Main Authors | , , , , , , , , , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
London
BioMed Central Ltd
07.09.2023
BioMed Central BMC |
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | Background UTX (encoded by KDM6A), a histone demethylase for H3K27me2/3, is frequently mutated in human cancers. However, its functional and regulatory mechanisms in colorectal cancer (CRC) remain unclear. Methods Immunohistochemistry staining was used to investigate the clinical relevance of UTX in CRC. Additionally, we generated a spontaneous mouse CRC model with conditional Utx knockout to explore the role of UTX in the colorectal tumorigenesis. Post-translational regulation of UTX was determined by co-immunoprecipitation and immunoblot analyses. Results Herein, we identify that downregulation of UTX, mediated by the Cullin 4B-DNA Damage Binding Protein-1-Constitutive Photomorphogenesis Protein 1 (CUL4B-DDB1-COP1) complex, promotes CRC progression. Utx deletion in intestinal epithelial cells enhanced the susceptibility to tumorigenesis in AOM/DSS-induced spontaneous mouse CRC model. However, this effect is primarily alleviated by GSK126, an inhibitor of histone methyltransferase EZH2. Mechanistically, EMP1 and AUTS2 are identified as putative UTX target genes mediating UTX functions in limiting intestinal tumorigenesis. Notably, the CUL4B-DDB1-COP1 complex is identified as the functional E3 ligase responsible for targeting UTX for degradation in CRC cells. Thus, Cop1 deficiency in mouse intestinal tissue results in UTX accumulation and restricts tumorigenesis. Furthermore, patient cohort analysis reveals that UTX expression is negatively correlated with clinical stage, favorable disease outcomes, and COP1 expression. Conclusions In the current study, the tumor suppressor function and regulation of UTX in CRC provide a molecular basis and the rationale to target EZH2 in UTX-deficient CRC. Keywords: Colorectal cancer, COP1, Ubiquitylation, UTX |
|---|---|
| AbstractList | Background UTX (encoded by KDM6A), a histone demethylase for H3K27me2/3, is frequently mutated in human cancers. However, its functional and regulatory mechanisms in colorectal cancer (CRC) remain unclear. Methods Immunohistochemistry staining was used to investigate the clinical relevance of UTX in CRC. Additionally, we generated a spontaneous mouse CRC model with conditional Utx knockout to explore the role of UTX in the colorectal tumorigenesis. Post-translational regulation of UTX was determined by co-immunoprecipitation and immunoblot analyses. Results Herein, we identify that downregulation of UTX, mediated by the Cullin 4B-DNA Damage Binding Protein-1-Constitutive Photomorphogenesis Protein 1 (CUL4B-DDB1-COP1) complex, promotes CRC progression. Utx deletion in intestinal epithelial cells enhanced the susceptibility to tumorigenesis in AOM/DSS-induced spontaneous mouse CRC model. However, this effect is primarily alleviated by GSK126, an inhibitor of histone methyltransferase EZH2. Mechanistically, EMP1 and AUTS2 are identified as putative UTX target genes mediating UTX functions in limiting intestinal tumorigenesis. Notably, the CUL4B-DDB1-COP1 complex is identified as the functional E3 ligase responsible for targeting UTX for degradation in CRC cells. Thus, Cop1 deficiency in mouse intestinal tissue results in UTX accumulation and restricts tumorigenesis. Furthermore, patient cohort analysis reveals that UTX expression is negatively correlated with clinical stage, favorable disease outcomes, and COP1 expression. Conclusions In the current study, the tumor suppressor function and regulation of UTX in CRC provide a molecular basis and the rationale to target EZH2 in UTX-deficient CRC. Keywords: Colorectal cancer, COP1, Ubiquitylation, UTX BackgroundUTX (encoded by KDM6A), a histone demethylase for H3K27me2/3, is frequently mutated in human cancers. However, its functional and regulatory mechanisms in colorectal cancer (CRC) remain unclear.MethodsImmunohistochemistry staining was used to investigate the clinical relevance of UTX in CRC. Additionally, we generated a spontaneous mouse CRC model with conditional Utx knockout to explore the role of UTX in the colorectal tumorigenesis. Post-translational regulation of UTX was determined by co-immunoprecipitation and immunoblot analyses.ResultsHerein, we identify that downregulation of UTX, mediated by the Cullin 4B-DNA Damage Binding Protein-1-Constitutive Photomorphogenesis Protein 1 (CUL4B-DDB1-COP1) complex, promotes CRC progression. Utx deletion in intestinal epithelial cells enhanced the susceptibility to tumorigenesis in AOM/DSS-induced spontaneous mouse CRC model. However, this effect is primarily alleviated by GSK126, an inhibitor of histone methyltransferase EZH2. Mechanistically, EMP1 and AUTS2 are identified as putative UTX target genes mediating UTX functions in limiting intestinal tumorigenesis. Notably, the CUL4B-DDB1-COP1 complex is identified as the functional E3 ligase responsible for targeting UTX for degradation in CRC cells. Thus, Cop1 deficiency in mouse intestinal tissue results in UTX accumulation and restricts tumorigenesis. Furthermore, patient cohort analysis reveals that UTX expression is negatively correlated with clinical stage, favorable disease outcomes, and COP1 expression.ConclusionsIn the current study, the tumor suppressor function and regulation of UTX in CRC provide a molecular basis and the rationale to target EZH2 in UTX-deficient CRC. UTX (encoded by KDM6A), a histone demethylase for H3K27me2/3, is frequently mutated in human cancers. However, its functional and regulatory mechanisms in colorectal cancer (CRC) remain unclear.BACKGROUNDUTX (encoded by KDM6A), a histone demethylase for H3K27me2/3, is frequently mutated in human cancers. However, its functional and regulatory mechanisms in colorectal cancer (CRC) remain unclear.Immunohistochemistry staining was used to investigate the clinical relevance of UTX in CRC. Additionally, we generated a spontaneous mouse CRC model with conditional Utx knockout to explore the role of UTX in the colorectal tumorigenesis. Post-translational regulation of UTX was determined by co-immunoprecipitation and immunoblot analyses.METHODSImmunohistochemistry staining was used to investigate the clinical relevance of UTX in CRC. Additionally, we generated a spontaneous mouse CRC model with conditional Utx knockout to explore the role of UTX in the colorectal tumorigenesis. Post-translational regulation of UTX was determined by co-immunoprecipitation and immunoblot analyses.Herein, we identify that downregulation of UTX, mediated by the Cullin 4B-DNA Damage Binding Protein-1-Constitutive Photomorphogenesis Protein 1 (CUL4B-DDB1-COP1) complex, promotes CRC progression. Utx deletion in intestinal epithelial cells enhanced the susceptibility to tumorigenesis in AOM/DSS-induced spontaneous mouse CRC model. However, this effect is primarily alleviated by GSK126, an inhibitor of histone methyltransferase EZH2. Mechanistically, EMP1 and AUTS2 are identified as putative UTX target genes mediating UTX functions in limiting intestinal tumorigenesis. Notably, the CUL4B-DDB1-COP1 complex is identified as the functional E3 ligase responsible for targeting UTX for degradation in CRC cells. Thus, Cop1 deficiency in mouse intestinal tissue results in UTX accumulation and restricts tumorigenesis. Furthermore, patient cohort analysis reveals that UTX expression is negatively correlated with clinical stage, favorable disease outcomes, and COP1 expression.RESULTSHerein, we identify that downregulation of UTX, mediated by the Cullin 4B-DNA Damage Binding Protein-1-Constitutive Photomorphogenesis Protein 1 (CUL4B-DDB1-COP1) complex, promotes CRC progression. Utx deletion in intestinal epithelial cells enhanced the susceptibility to tumorigenesis in AOM/DSS-induced spontaneous mouse CRC model. However, this effect is primarily alleviated by GSK126, an inhibitor of histone methyltransferase EZH2. Mechanistically, EMP1 and AUTS2 are identified as putative UTX target genes mediating UTX functions in limiting intestinal tumorigenesis. Notably, the CUL4B-DDB1-COP1 complex is identified as the functional E3 ligase responsible for targeting UTX for degradation in CRC cells. Thus, Cop1 deficiency in mouse intestinal tissue results in UTX accumulation and restricts tumorigenesis. Furthermore, patient cohort analysis reveals that UTX expression is negatively correlated with clinical stage, favorable disease outcomes, and COP1 expression.In the current study, the tumor suppressor function and regulation of UTX in CRC provide a molecular basis and the rationale to target EZH2 in UTX-deficient CRC.CONCLUSIONSIn the current study, the tumor suppressor function and regulation of UTX in CRC provide a molecular basis and the rationale to target EZH2 in UTX-deficient CRC. Abstract Background UTX (encoded by KDM6A), a histone demethylase for H3K27me2/3, is frequently mutated in human cancers. However, its functional and regulatory mechanisms in colorectal cancer (CRC) remain unclear. Methods Immunohistochemistry staining was used to investigate the clinical relevance of UTX in CRC. Additionally, we generated a spontaneous mouse CRC model with conditional Utx knockout to explore the role of UTX in the colorectal tumorigenesis. Post-translational regulation of UTX was determined by co-immunoprecipitation and immunoblot analyses. Results Herein, we identify that downregulation of UTX, mediated by the Cullin 4B-DNA Damage Binding Protein-1-Constitutive Photomorphogenesis Protein 1 (CUL4B-DDB1-COP1) complex, promotes CRC progression. Utx deletion in intestinal epithelial cells enhanced the susceptibility to tumorigenesis in AOM/DSS-induced spontaneous mouse CRC model. However, this effect is primarily alleviated by GSK126, an inhibitor of histone methyltransferase EZH2. Mechanistically, EMP1 and AUTS2 are identified as putative UTX target genes mediating UTX functions in limiting intestinal tumorigenesis. Notably, the CUL4B-DDB1-COP1 complex is identified as the functional E3 ligase responsible for targeting UTX for degradation in CRC cells. Thus, Cop1 deficiency in mouse intestinal tissue results in UTX accumulation and restricts tumorigenesis. Furthermore, patient cohort analysis reveals that UTX expression is negatively correlated with clinical stage, favorable disease outcomes, and COP1 expression. Conclusions In the current study, the tumor suppressor function and regulation of UTX in CRC provide a molecular basis and the rationale to target EZH2 in UTX-deficient CRC. UTX (encoded by KDM6A), a histone demethylase for H3K27me2/3, is frequently mutated in human cancers. However, its functional and regulatory mechanisms in colorectal cancer (CRC) remain unclear. Immunohistochemistry staining was used to investigate the clinical relevance of UTX in CRC. Additionally, we generated a spontaneous mouse CRC model with conditional Utx knockout to explore the role of UTX in the colorectal tumorigenesis. Post-translational regulation of UTX was determined by co-immunoprecipitation and immunoblot analyses. Herein, we identify that downregulation of UTX, mediated by the Cullin 4B-DNA Damage Binding Protein-1-Constitutive Photomorphogenesis Protein 1 (CUL4B-DDB1-COP1) complex, promotes CRC progression. Utx deletion in intestinal epithelial cells enhanced the susceptibility to tumorigenesis in AOM/DSS-induced spontaneous mouse CRC model. However, this effect is primarily alleviated by GSK126, an inhibitor of histone methyltransferase EZH2. Mechanistically, EMP1 and AUTS2 are identified as putative UTX target genes mediating UTX functions in limiting intestinal tumorigenesis. Notably, the CUL4B-DDB1-COP1 complex is identified as the functional E3 ligase responsible for targeting UTX for degradation in CRC cells. Thus, Cop1 deficiency in mouse intestinal tissue results in UTX accumulation and restricts tumorigenesis. Furthermore, patient cohort analysis reveals that UTX expression is negatively correlated with clinical stage, favorable disease outcomes, and COP1 expression. In the current study, the tumor suppressor function and regulation of UTX in CRC provide a molecular basis and the rationale to target EZH2 in UTX-deficient CRC. |
| ArticleNumber | 77 |
| Audience | Academic |
| Author | Liang, Lei Fu, Guoxiang Wang, Kaihua Shan, Zezhi Luo, Dakui Qin, Jun Gao, Daming Li, Qingguo Liu, Qi Qin, Yi Li, Xinxiang Li, Junqiang Ma, Yanlei Chen, Min Yang, Yufei Wang, Kangjunjie |
| Author_xml | – sequence: 1 givenname: Dakui surname: Luo fullname: Luo, Dakui – sequence: 2 givenname: Min surname: Chen fullname: Chen, Min – sequence: 3 givenname: Qingguo surname: Li fullname: Li, Qingguo – sequence: 4 givenname: Kangjunjie surname: Wang fullname: Wang, Kangjunjie – sequence: 5 givenname: Kaihua surname: Wang fullname: Wang, Kaihua – sequence: 6 givenname: Junqiang surname: Li fullname: Li, Junqiang – sequence: 7 givenname: Guoxiang surname: Fu fullname: Fu, Guoxiang – sequence: 8 givenname: Zezhi surname: Shan fullname: Shan, Zezhi – sequence: 9 givenname: Qi surname: Liu fullname: Liu, Qi – sequence: 10 givenname: Yufei surname: Yang fullname: Yang, Yufei – sequence: 11 givenname: Lei surname: Liang fullname: Liang, Lei – sequence: 12 givenname: Yanlei surname: Ma fullname: Ma, Yanlei – sequence: 13 givenname: Yi surname: Qin fullname: Qin, Yi – sequence: 14 givenname: Jun surname: Qin fullname: Qin, Jun – sequence: 15 givenname: Daming surname: Gao fullname: Gao, Daming – sequence: 16 givenname: Xinxiang surname: Li fullname: Li, Xinxiang |
| BookMark | eNp9kl9rFDEUxQepYK39Aj4NCOLLtPk3SeZJ2q3awkJFuuBbyCR3ZrNkJ2syU7Gf3uxuxW4Rk4eE3N85ITfndXE0hAGK4i1GZxhLfp4YwpxViNAKIcZQ9fCiOCaYk4py3Bw92b8qTlNaoTw44RKL4-LbbDFnl9XV1SWuZrdfcbUG6_QItlzcfS9t-DlE6CevRxeGchPDOoyQShN8iGBG7UujBwNxW-ojpJSxN8XLTvsEp4_rSbH4_Oludl3Nb7_czC7mlakFGau6NahFTGDR1JJAZ2jXWkq5kajljSGMAxFSyAY1mgDLRd4KZpElLdGUGHpS3Ox9bdArtYlureMvFbRTu4MQe6Xj6IwHJWvBrW2IZY1lmPKGIN4ayyyuGQahs9fHvddmanMHDAxj1P7A9LAyuKXqw73CiEkqCM8OHx4dYvgxQRrV2iUD3usBwpQUkZzS3HfUZPTdM3QVpjjkXm2pmjFeE_mX6nV-gRu6kC82W1N1IThDqKkJydTZP6g8LaydyTnpXD4_ELx_IliC9uMyBT9tPzgdgnIPmhhSitAp48ZdDvINzueXq2361D59KqdP7dKnHrKUPJP-aeR_RL8BOkvbZA |
| CitedBy_id | crossref_primary_10_1111_jcmm_18247 crossref_primary_10_1615_CritRevEukaryotGeneExpr_2024054038 crossref_primary_10_1038_s12276_024_01329_5 crossref_primary_10_1186_s40164_024_00474_x crossref_primary_10_1002_advs_202415956 crossref_primary_10_1016_j_biopha_2024_116488 crossref_primary_10_3390_cells14020063 crossref_primary_10_1016_j_bbcan_2024_189169 |
| Cites_doi | 10.1007/s13277-013-1456-x 10.1038/leu.2012.56 10.1038/s41375-018-0011-6 10.1016/j.pbi.2017.03.015 10.1136/jcp.2010.082404 10.2147/OTT.S240028 10.3322/caac.21660 10.1371/journal.pgen.1002964 10.1016/j.celrep.2017.09.078 10.1038/nature02514 10.1016/j.ccell.2020.07.008 10.1038/nrd1254 10.1126/science.aax3769 10.1016/j.ccell.2019.01.001 10.3748/wjg.v20.i14.4001 10.1038/s41575-019-0230-y 10.1038/nature10005 10.1038/nature01075 10.1136/gutjnl-2020-322835 10.1186/s12935-019-0841-y 10.1073/pnas.1210787109 10.1038/nrc3271 10.1038/nature13921 10.1186/s40164-023-00405-2 10.1053/j.gastro.2017.11.004 10.1038/nature17416 10.1038/leu.2014.80 10.1038/nature11125 10.1038/nm.3968 10.1038/ng.349 10.1016/j.cancergen.2020.04.077 10.1186/s13045-021-01041-1 10.1073/pnas.0502113102 10.1016/j.tibs.2009.07.002 10.1038/s41467-019-10176-2 10.1038/s41467-018-05084-w 10.1002/jcb.28974 10.1101/gad.5.7.1172 10.1126/science.1093549 10.1038/s41388-018-0286-0 10.1158/2159-8290.CD-19-0463 |
| ContentType | Journal Article |
| Copyright | COPYRIGHT 2023 BioMed Central Ltd. 2023. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. 2023. YUMED Inc. and BioMed Central Ltd. YUMED Inc. and BioMed Central Ltd. 2023 |
| Copyright_xml | – notice: COPYRIGHT 2023 BioMed Central Ltd. – notice: 2023. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: 2023. YUMED Inc. and BioMed Central Ltd. – notice: YUMED Inc. and BioMed Central Ltd. 2023 |
| DBID | AAYXX CITATION 3V. 7X7 7XB 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH K9. M0S PHGZM PHGZT PIMPY PKEHL PQEST PQQKQ PQUKI PRINS 7X8 5PM DOA |
| DOI | 10.1186/s40164-023-00440-z |
| DatabaseName | CrossRef ProQuest Central (Corporate) ProQuest Health & Medical Collection ProQuest Central (purchase pre-March 2016) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central ProQuest One ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) ProQuest Health & Medical Collection ProQuest Central Premium ProQuest One Academic (New) Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) Directory of Open Access Journals |
| DatabaseTitle | CrossRef Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest One Academic Eastern Edition ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Central China ProQuest Hospital Collection (Alumni) ProQuest Central ProQuest Health & Medical Complete Health Research Premium Collection ProQuest One Academic UKI Edition Health and Medicine Complete (Alumni Edition) ProQuest Central Korea ProQuest Central (New) ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | Publicly Available Content Database MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: 7X7 name: Health & Medical Collection url: https://search.proquest.com/healthcomplete sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 2162-3619 |
| EndPage | 21 |
| ExternalDocumentID | oai_doaj_org_article_8576dd92d49d41369206bcd4d1541e7a PMC10483726 A764009522 10_1186_s40164_023_00440_z |
| GeographicLocations | China |
| GeographicLocations_xml | – name: China |
| GrantInformation_xml | – fundername: ; grantid: 82103259, 81972260, 81925029, 82230098, 32221002, 81790253; 82103259, 81972260, 81925029, 82230098, 32221002, 81790253; 82103259, 81972260, 81925029, 82230098, 32221002, 81790253 – fundername: ; grantid: 2020YFA0803203 and 2019YFA0802102 – fundername: ; grantid: YSBR-014 – fundername: ; grantid: JCTD-2018-14 |
| GroupedDBID | 0R~ 53G 5VS 7X7 8FI 8FJ AAFWJ AAJSJ AASML AAYXX ABDBF ABUWG ACGFS ACUHS ADBBV ADRAZ ADUKV AFKRA AFPKN AHBYD AHYZX ALIPV ALMA_UNASSIGNED_HOLDINGS AMKLP AOIJS BCNDV BENPR BFQNJ BMC BPHCQ BVXVI C6C CCPQU CITATION EBLON EBS FYUFA GROUPED_DOAJ HMCUK HYE IAO IHR IHW ITC KQ8 M48 M~E OK1 PGMZT PHGZM PHGZT PIMPY PQQKQ PROAC RBZ ROL RPM RSV SMD SOJ UKHRP PMFND 3V. 7XB 8FK AZQEC DWQXO K9. PKEHL PQEST PQUKI PRINS 7X8 5PM PUEGO |
| ID | FETCH-LOGICAL-c572t-5bc0b047179582efc3fbd336c80b69c246e27878909a2e4fbd6b74d0d2b2a32c3 |
| IEDL.DBID | M48 |
| ISSN | 2162-3619 |
| IngestDate | Wed Aug 27 00:59:43 EDT 2025 Thu Aug 21 18:36:31 EDT 2025 Fri Jul 11 09:01:52 EDT 2025 Mon Jun 30 05:46:36 EDT 2025 Tue Jun 17 22:25:37 EDT 2025 Tue Jun 10 21:21:08 EDT 2025 Thu May 22 21:20:02 EDT 2025 Thu Apr 24 23:12:26 EDT 2025 Tue Jul 01 04:08:29 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 1 |
| Language | English |
| License | Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c572t-5bc0b047179582efc3fbd336c80b69c246e27878909a2e4fbd6b74d0d2b2a32c3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
| OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.1186/s40164-023-00440-z |
| PQID | 2865446528 |
| PQPubID | 2040239 |
| PageCount | 21 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_8576dd92d49d41369206bcd4d1541e7a pubmedcentral_primary_oai_pubmedcentral_nih_gov_10483726 proquest_miscellaneous_2863300609 proquest_journals_2865446528 gale_infotracmisc_A764009522 gale_infotracacademiconefile_A764009522 gale_healthsolutions_A764009522 crossref_citationtrail_10_1186_s40164_023_00440_z crossref_primary_10_1186_s40164_023_00440_z |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2023-09-07 |
| PublicationDateYYYYMMDD | 2023-09-07 |
| PublicationDate_xml | – month: 09 year: 2023 text: 2023-09-07 day: 07 |
| PublicationDecade | 2020 |
| PublicationPlace | London |
| PublicationPlace_xml | – name: London |
| PublicationTitle | Experimental hematology & oncology |
| PublicationYear | 2023 |
| Publisher | BioMed Central Ltd BioMed Central BMC |
| Publisher_xml | – name: BioMed Central Ltd – name: BioMed Central – name: BMC |
| References | H Sung (440_CR1) 2021; 71 EM Stoffel (440_CR2) 2018; 154 X Li (440_CR17) 2018; 9 IM Aries (440_CR33) 2014; 28 B Wang (440_CR40) 2023; 12 T Ezponda (440_CR18) 2017; 21 S Varambally (440_CR38) 2002; 419 Q Wu (440_CR16) 2018; 115 AC Vitari (440_CR27) 2011; 474 C Pohl (440_CR20) 2019; 366 G van Haaften (440_CR12) 2009; 41 KH Kim (440_CR39) 2015; 21 E Orouji (440_CR4) 2022; 71 X Tang (440_CR19) 2019; 19 G Jung (440_CR3) 2020; 17 JC Marine (440_CR25) 2012; 12 CS Grasso (440_CR14) 2012; 487 KB Shpargel (440_CR10) 2012; 8 L Wang (440_CR9) 2019; 35 Z Gao (440_CR30) 2014; 516 U Hoecker (440_CR24) 2017; 37 J Wang (440_CR31) 2019; 120 Y Liu (440_CR32) 2020; 13 J Zhou (440_CR37) 2019; 10 GG Sun (440_CR36) 2014; 35 MKB Ahmat Amin (440_CR34) 2018; 37 Y Qian (440_CR7) 2020; 245 C Chung (440_CR6) 2020; 38 BG Mar (440_CR13) 2012; 26 S Jackson (440_CR22) 2009; 34 D Dornan (440_CR28) 2004; 429 GG Welstead (440_CR11) 2012; 109 GG Sun (440_CR35) 2014; 20 L Zheng (440_CR15) 2018; 32 A Jain (440_CR41) 2005; 102 TL Clarke (440_CR5) 2020; 10 GJ Yang (440_CR8) 2021; 14 G Sauter (440_CR29) 2003; 2 XW Deng (440_CR23) 1991; 5 IE Wertz (440_CR26) 2004; 303 S Cavadini (440_CR21) 2016; 531 J Zhang (440_CR42) 2011; 64 |
| References_xml | – volume: 35 start-page: 3455 issue: 4 year: 2014 ident: 440_CR36 publication-title: Tumour Biol doi: 10.1007/s13277-013-1456-x – volume: 26 start-page: 1881 issue: 8 year: 2012 ident: 440_CR13 publication-title: Leukemia doi: 10.1038/leu.2012.56 – volume: 32 start-page: 1458 issue: 6 year: 2018 ident: 440_CR15 publication-title: Leukemia doi: 10.1038/s41375-018-0011-6 – volume: 37 start-page: 63 year: 2017 ident: 440_CR24 publication-title: Curr Opin Plant Biol doi: 10.1016/j.pbi.2017.03.015 – volume: 64 start-page: 25 issue: 1 year: 2011 ident: 440_CR42 publication-title: J Clin Pathol doi: 10.1136/jcp.2010.082404 – volume: 13 start-page: 2047 year: 2020 ident: 440_CR32 publication-title: Onco Targets Ther doi: 10.2147/OTT.S240028 – volume: 71 start-page: 209 issue: 3 year: 2021 ident: 440_CR1 publication-title: CA Cancer J Clin doi: 10.3322/caac.21660 – volume: 8 issue: 9 year: 2012 ident: 440_CR10 publication-title: PLoS Genet doi: 10.1371/journal.pgen.1002964 – volume: 21 start-page: 628 issue: 3 year: 2017 ident: 440_CR18 publication-title: Cell Rep doi: 10.1016/j.celrep.2017.09.078 – volume: 429 start-page: 86 issue: 6987 year: 2004 ident: 440_CR28 publication-title: Nature doi: 10.1038/nature02514 – volume: 38 start-page: 334 issue: 3 year: 2020 ident: 440_CR6 publication-title: Cancer Cell. doi: 10.1016/j.ccell.2020.07.008 – volume: 2 start-page: 962 issue: 12 year: 2003 ident: 440_CR29 publication-title: Nat Rev Drug Discov doi: 10.1038/nrd1254 – volume: 366 start-page: 818 issue: 6467 year: 2019 ident: 440_CR20 publication-title: Science doi: 10.1126/science.aax3769 – volume: 35 start-page: 168 issue: 2 year: 2019 ident: 440_CR9 publication-title: Cancer Cell doi: 10.1016/j.ccell.2019.01.001 – volume: 20 start-page: 4001 issue: 14 year: 2014 ident: 440_CR35 publication-title: World J Gastroenterol doi: 10.3748/wjg.v20.i14.4001 – volume: 17 start-page: 111 issue: 2 year: 2020 ident: 440_CR3 publication-title: Nat Rev Gastroenterol Hepatol doi: 10.1038/s41575-019-0230-y – volume: 474 start-page: 403 issue: 7351 year: 2011 ident: 440_CR27 publication-title: Nature doi: 10.1038/nature10005 – volume: 419 start-page: 624 issue: 6907 year: 2002 ident: 440_CR38 publication-title: Nature doi: 10.1038/nature01075 – volume: 71 start-page: 938 issue: 5 year: 2022 ident: 440_CR4 publication-title: Gut doi: 10.1136/gutjnl-2020-322835 – volume: 19 start-page: 144 year: 2019 ident: 440_CR19 publication-title: Cancer Cell Int doi: 10.1186/s12935-019-0841-y – volume: 109 start-page: 13004 issue: 32 year: 2012 ident: 440_CR11 publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.1210787109 – volume: 12 start-page: 455 issue: 7 year: 2012 ident: 440_CR25 publication-title: Nat Rev Cancer doi: 10.1038/nrc3271 – volume: 516 start-page: 349 issue: 7531 year: 2014 ident: 440_CR30 publication-title: Nature doi: 10.1038/nature13921 – volume: 12 start-page: 52 issue: 1 year: 2023 ident: 440_CR40 publication-title: Exp Hematol Oncol doi: 10.1186/s40164-023-00405-2 – volume: 154 start-page: 897 issue: 4 year: 2018 ident: 440_CR2 publication-title: Gastroenterology. doi: 10.1053/j.gastro.2017.11.004 – volume: 531 start-page: 598 issue: 7596 year: 2016 ident: 440_CR21 publication-title: Nature doi: 10.1038/nature17416 – volume: 28 start-page: 1828 issue: 9 year: 2014 ident: 440_CR33 publication-title: Leukemia doi: 10.1038/leu.2014.80 – volume: 487 start-page: 239 issue: 7406 year: 2012 ident: 440_CR14 publication-title: Nature doi: 10.1038/nature11125 – volume: 21 start-page: 1491 issue: 12 year: 2015 ident: 440_CR39 publication-title: Nat Med doi: 10.1038/nm.3968 – volume: 41 start-page: 521 issue: 5 year: 2009 ident: 440_CR12 publication-title: Nat Genet doi: 10.1038/ng.349 – volume: 115 start-page: E3978 issue: 17 year: 2018 ident: 440_CR16 publication-title: Proc Natl Acad Sci U S A – volume: 245 start-page: 17 year: 2020 ident: 440_CR7 publication-title: Cancer Genet doi: 10.1016/j.cancergen.2020.04.077 – volume: 14 start-page: 30 issue: 1 year: 2021 ident: 440_CR8 publication-title: J Hematol Oncol doi: 10.1186/s13045-021-01041-1 – volume: 102 start-page: 11858 issue: 33 year: 2005 ident: 440_CR41 publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.0502113102 – volume: 34 start-page: 562 issue: 11 year: 2009 ident: 440_CR22 publication-title: Trends Biochem Sci doi: 10.1016/j.tibs.2009.07.002 – volume: 10 start-page: 2427 issue: 1 year: 2019 ident: 440_CR37 publication-title: Nat Commun doi: 10.1038/s41467-019-10176-2 – volume: 9 start-page: 2720 issue: 1 year: 2018 ident: 440_CR17 publication-title: Nat Commun doi: 10.1038/s41467-018-05084-w – volume: 120 start-page: 17142 issue: 10 year: 2019 ident: 440_CR31 publication-title: J Cell Biochem doi: 10.1002/jcb.28974 – volume: 5 start-page: 1172 issue: 7 year: 1991 ident: 440_CR23 publication-title: Genes Dev doi: 10.1101/gad.5.7.1172 – volume: 303 start-page: 1371 issue: 5662 year: 2004 ident: 440_CR26 publication-title: Science doi: 10.1126/science.1093549 – volume: 37 start-page: 5416 issue: 40 year: 2018 ident: 440_CR34 publication-title: Oncogene doi: 10.1038/s41388-018-0286-0 – volume: 10 start-page: 306 issue: 2 year: 2020 ident: 440_CR5 publication-title: Cancer Discov doi: 10.1158/2159-8290.CD-19-0463 |
| SSID | ssj0000626817 |
| Score | 2.338019 |
| Snippet | Background UTX (encoded by KDM6A), a histone demethylase for H3K27me2/3, is frequently mutated in human cancers. However, its functional and regulatory... UTX (encoded by KDM6A), a histone demethylase for H3K27me2/3, is frequently mutated in human cancers. However, its functional and regulatory mechanisms in... BackgroundUTX (encoded by KDM6A), a histone demethylase for H3K27me2/3, is frequently mutated in human cancers. However, its functional and regulatory... Abstract Background UTX (encoded by KDM6A), a histone demethylase for H3K27me2/3, is frequently mutated in human cancers. However, its functional and... |
| SourceID | doaj pubmedcentral proquest gale crossref |
| SourceType | Open Website Open Access Repository Aggregation Database Enrichment Source Index Database |
| StartPage | 1 |
| SubjectTerms | Analysis Antibodies Biochemistry Colorectal cancer COP1 Development and progression Drinking water Gene expression Histones Laboratory animals Ligases Methyltransferases Mutation Phosphatase Protein binding Proteins Tumorigenesis Tumors Ubiquitylation UTX X chromosomes |
| SummonAdditionalLinks | – databaseName: Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1LT9wwELYqDqgXRKEV4dVUqsShskgcx48juxShqhSEWGlvVvxYgYSyaHe58Os7Y2dXmyLRC9d4bMXjeTmZ-YaQ70ooCIpVQVXjsCSndlTVakILYb1ULkipsTj56o-4HPFf43q81uoLc8ISPHBi3KmCgNh7zTzXHgyu0AyWcZ578P1lkDE0Ap-3dplKNpgJVcpllYwSp3OOYFIUXBSNbZbpS88TRcD-12b531TJNd9zsU22uqAxP0sv-4l8CO0O2bzqfovvktvh6Dcf0PPzQUmH1zcljfUgEEvmo7tx7uGiPUst5-EQ8qeYgBfmOeJVo72DlR2e_SyPyVoJqOMzGV38vBte0q5ZAnW1ZAtaW1fYAlyN1LViYeKqifVVJZwqrNCOcREYKKfShW5Y4DAorOS-8MyypmKu-kI22mkb9kjeAEHpeWG1sFxK0YgSP01YCEb8pGIqI-WSccZ1SOLY0OLRxBuFEiYx2wCzTWS2ecnIj9Wcp4Sj8Sb1AM9jRYkY2PEBSIbpJMP8TzIy8hVP06SC0pUmmzMpOEaWjGXkJFKgLsMGXNOVJAAbEBWrR3nYowQddP3hpcSYzgbMDdb8IhwdMuzbahhnYl5bG6bPkaaqEBNHZ0T1JK239_5I-3AfccDL2A6Aif334NYB-ciicmBN2yHZWMyewxHEWwt7HFXrLw9CI5s priority: 102 providerName: Directory of Open Access Journals – databaseName: ProQuest Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3daxQxEA9aQXwR6weuVl1B8EFCs9lsPp6kd7UUsSrSg3sLm4_TQtk7764v_eudyeZWt0JfN5NddjJfSWZ-Q8g7LTUExZpR3XosyWk81Y1eUCZdUNpHpQwWJ599lacz8XnezPOB2yanVe5sYjLUYenxjPwQKygR3Ivrj6vfFLtG4e1qbqFxl9xD6DJM6VJzNZyxMIjWdaV2tTJaHm4EQkpRcFQ0NVum1yN_lGD7_zfONxMm__FAJ4_Iwxw6lkf9Wu-TO7F7TO6f5cvxJ-THdPZFTOjx8aSi02_fK5qqQiCiLGfn8zLAdnvdN56HpShXKQ0vbkpErUarB2_2KAHrMqVs9XAdT8ns5NP59JTmlgnUN4pvaeM8cwwcjgJu8Ljw9cKFupZeMyeN50JGDiqqDTMtjwIGpVMisMAdb2vu62dkr1t28TkpWyCogmDOSCeUkq2s8IDCQUgSFjXXBal2jLM-44ljW4tLm_YVWtqe2RaYbROz7XVBPgxzVj2axq3UE1yPgRKRsNOD5fqnzYplNWyYQjA8CBPAIUvDQcx8EAFiwyqqtiBvcDVtX1Y66LM9UlJgfMl5Qd4nCtRo-AHf5sIEYANiY40oD0aUoIl-PLyTGJstwcb-lduCvB2GcSZmt3VxeZVo6hqRcUxB9EjSRv8-HukufiU08Co1BeDyxe1ff0ke8CT2WLN2QPa266v4CuKprXudlOYPzYYbxg priority: 102 providerName: ProQuest |
| Title | CUL4B-DDB1-COP1-mediated UTX downregulation promotes colorectal cancer progression |
| URI | https://www.proquest.com/docview/2865446528 https://www.proquest.com/docview/2863300609 https://pubmed.ncbi.nlm.nih.gov/PMC10483726 https://doaj.org/article/8576dd92d49d41369206bcd4d1541e7a |
| Volume | 12 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3da9swEBf9gLGXsU_mtcs8GOxhaLNlWR8PYyRpSwlLV7oG8iYsyekGxWmdFLb-9buT7TBvpU8G6ySs053uTtb9jpB3SihwilVCVeEwJSd3VOVqQRNhvVSulFJjcvL0RBzP-GSez7dIV-6oZeDqztAO60nN6suPv65_fwGF_xwUXolPK444URSsDw0VlOntNtkFyyRRUaetu9_szEyoUISXpYLRDIKHLo_mzmF6tipA-v-_cf97mfIv63T0mDxq3cp42MjBE7JVVk_Jg2n74_wZORvPvvIRPTgYpXT87TSlIWMEvM14dj6PPYTidVOUHpYpvgpX9MpVjIjWuCPCyA6lo47Dda4GyuM5mR0dno-PaVtOgbpcsjXNrUtsAsZI6lyxcuGyhfVZJpxKrNCOcVEyUF-lE12wkkOjsJL7xDPLioy57AXZqZZV-ZLEBRCknidWC8ulFIVI8fDCgrviFxlTEUk7xhnXYo1jyYtLE2IOJUzDbAPMNoHZ5jYiHzZ9rhqkjXupR7geG0pEyQ4vlvWFaZXOKAimvNfMc-3BWAvNQASd5x78xrSURUTe4GqaJuV0o-tmKAVH35OxiLwPFCh_MAFXtEkLwAbEzepR7vcoQUtdv7mTGNMJucGsYASsQ4a93TRjT7z5VpXLm0CTZYiaoyOiepLWm3u_pfr5IyCFp6FgABOv7v-4PfKQBbHHfLZ9srOub8rX4Gut7YBsy7kckN3hcPJ9As_R4cnp2SCcXAyCcv0B_3slpg |
| linkProvider | Scholars Portal |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwELdGJwEviE8RGCxIIB6QtcRxHOcBobXd1LG2TFMr9c2LPwpIKC1tJ8T-KP5G7pykEJD2ttf44sjnu_Odc_c7Ql5LIcEplhGVhcGSnNRQmco5jYS2mTQuy3IsTh6NxWDKP87S2Q751dTCYFplYxO9obYLg3fkB1hBieBeTH5YfqfYNQr_rjYtNCqxOHU_f0DItn5_0of9fcPY8dGkN6B1VwFq0oxtaKpNpCOwyVmeSubmJplrmyTCyEiL3DAuHAMplnmUF8xxGBQ64zayTLMiYSaBeW-RXZ5AKNMhu92j8dn59lYngvhAxllTnSPFwZojiBWFo5H69s70qnUC-kYB_x8H_6Zo_nXmHd8n92pnNTyspOsB2XHlQ3J7VP-Of0TOe9Mh79J-vxvT3qezmPo6FPBhw-lkFloI8FdVq3vY_HDpE__cOkScbLSzMLNBmVuFPkmsAgh5TKY3ws4npFMuSveUhAUQxJZHOheaZ5koRIxXIhqcIDtPmAxI3DBOmRrBHBtpfFM-kpFCVcxWwGzlma2uAvJu-86ywu-4lrqL-7GlROxt_2Cx-qxqVVYSQjRrc2Z5bsEFEDkDwTaWW_BGY5cVAdnH3VRVIevWgqjDTHD0aBkLyFtPgTYEFmCKuhQC2IBoXC3KvRYl6L5pDzcSo2rbs1Z_NCUgr7bD-Cbm05VucelpkgSxePKAyJaktdbeHim_fvH447FvQ8DEs-u_vk_uDCajoRqejE-fk7vMqwBWzO2RzmZ16V6AN7fRL2sVCsnFTWvtb3tcWc0 |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=CUL4B-DDB1-COP1-mediated+UTX+downregulation+promotes+colorectal+cancer+progression&rft.jtitle=Experimental+hematology+%26+oncology&rft.au=Luo%2C+Dakui&rft.au=Chen%2C+Min&rft.au=Li%2C+Qingguo&rft.au=Wang%2C+Kangjunjie&rft.date=2023-09-07&rft.pub=BioMed+Central+Ltd&rft.issn=2162-3619&rft.eissn=2162-3619&rft.volume=12&rft.issue=1&rft_id=info:doi/10.1186%2Fs40164-023-00440-z&rft.externalDocID=A764009522 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2162-3619&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2162-3619&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2162-3619&client=summon |